|Title:||Penciclovir for the treatment of post therapeutic neuralgia|
|Abstract:||A method for the treatment of PHN in mammals, including humans, which method comprises administering an effective amount of a compound of formula (A), or a pharmaceutically acceptable salt thereof. ##STR1##|
|Inventor(s):||Boon; Ronald James (Dorking, GB2), Griffin; David Ronald John (Bishop's Stortford, GB2)|
|Assignee:||SmithKline Beecham p.l.c. (Brentford, GB2)|
Patent Claim Types:|
see list of patent claims
Field: Not categorized
Back Citations: 2nd percentile
Forward Citations: 1st percentile
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|United Kingdom||9320485||Oct 05, 1993|
|United Kingdom||9321255||Oct 14, 1993|
|PCT Filed||October 04, 1994||PCT Application Number:||PCT/GB94/02156|
|PCT Publication Date:||April 13, 1995||PCT Publication Number:||WO95/09632|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|African Regional IP Organization (ARIPO)||616||► subscribe|
|African Regional IP Organization (ARIPO)||9400684||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.